COMPLETED

TACAD Program for Asian American Family Caregivers of Persons Living With Alzheimer's Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the proposed study is to preliminarily evaluate Technology-based information and coaching/support program that is tailored for Asian American midlife women who are family caregivers of patients living with Alzheimer's disease (TACAD) in improving health outcomes of Asian American midlife women who are family caregivers of persons living with Alzheimer's disease (AACA) and their care recipients.

Official Title

To Reduce the Burden of Caregiving on Health Outcomes of Midlife Women: Asian American Family Caregivers of Persons Living With Alzheimer's Disease

Quick Facts

Study Start:2024-04-05
Study Completion:2025-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05615233

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years to 65 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * self reported Asian American midlife women who are family caregivers of persons living with Alzheimer's disease (AACA).
  2. * Participants will be included if, by self-report, they are Asian American women aged 40 to 65 years old who identify as Chinese or Korean;
  3. * are family caregivers of PLAD;
  4. * can read and write English, Mandarin Chinese or Korean;
  5. * who reside in the U.S.;
  6. * have access to the Internet through computers or mobile devices.
  7. * Participants must be providing at least 4 hours per day unpaid assistance, on average, for a community-dwelling person in the early-middle stage of illness (Clinical Dementia Rating of 1) for whom there is no plan for institutionalization in six months.
  8. * Caregivers may or may not reside with their care recipient.
  1. * Those who used the AA website previously and/or participated in other studies related to AD will be excluded.

Contacts and Locations

Principal Investigator

Eun-Ok Im, PhD, MPH
PRINCIPAL_INVESTIGATOR
University of Texas at Austin

Study Locations (Sites)

University of Texas at Austin
Austin, Texas, 78712
United States

Collaborators and Investigators

Sponsor: University of Texas at Austin

  • Eun-Ok Im, PhD, MPH, PRINCIPAL_INVESTIGATOR, University of Texas at Austin

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-05
Study Completion Date2025-08-31

Study Record Updates

Study Start Date2024-04-05
Study Completion Date2025-08-31

Terms related to this study

Keywords Provided by Researchers

  • Caregiver

Additional Relevant MeSH Terms

  • Alzheimer Disease